Q-omics provides the consensus-scored KIR3DS1 profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for KIR3DS1 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with KIR3DS1 in patient tissues and cancer cell lines. In cancer cell lines, KIR3DS1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BONE, while CRISPR and shRNA rows add functional-dependency signals in CNS.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
shRNA	1,878	BONE (176)	view →
RNA	1,802	CNS (441)	view →